A phase 2 liver trial where the add-on drug didn't help — and the base drug quietly did
Read the Sunday Brief →

Study wrapper · #1043

Advances in proteomics research related to semaglutide: evidence from humans and animals.

Jia Q, Mu H, Wang Y, et al. Journal of endocrinological investigation. 2026.
MixedReviewMentions: Semaglutide

Editor's note

This is a narrative review synthesizing proteomic studies rather than new primary data, and it is descriptive rather than outcome-focused. It offers a useful molecular framework for the biological responses associated with semaglutide, but the authors emphasize small sample sizes and platform heterogeneity as major limitations. The recurring pathway signals are worth noting while remaining preliminary.

Plain-language abstract

This review pulls together 16 human and animal studies that used proteomics to map the protein and pathway changes associated with semaglutide across many tissues. Recurring signals involved fatty acid metabolism, mitochondrial function, and inflammatory pathways, though the authors caution that the underlying studies were small and methodologically varied.